Close

Nosocomial outbreaks caused by Acinetobacter baumannii and Pseudomonas aeruginosa: Results of a systematic review

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Chinese Medtech Companies Reshape Healthcare by Innovation

The worldwide medtech spectrum is undergoing a phenomenal shift,...

The Benefits of Virtual GP Insurance: A Game Changer for Modern Healthcare

In today’s fast-paced world, accessing healthcare quickly and efficiently...

Five Data Management Questions for MedTech Leaders

Healthcare is awash in data – medical device data,...

Vaxxas Secures U.S. Patent for HD-MAP Vaccine Technology

Vaxxas, a clinical-stage biotech firm has obtained a new...

In view of the large outbreaks of infection by Acinetobacter baumannii and Pseudomonas aeruginosa, researchers sought to determine risk factors for the occurrence and appropriate infection control measures.

They observed that Acinetobacter outbreaks were mainly reported from intensive care units, after use of antibiotics and during mechanical ventilation. Outbreaks caused by P. aeruginosa affected intensive care units (ICUs) and peripheral wards equally.

In Acinetobacter outbreaks, mortality was twice as high as in Pseudomonas outbreaks. The mortality rates were not influenced by resistance profiles of either pathogen. These findings should support staff in Infection Control Departments and on wards if an outbreak is suspected.

They here suggested the necessity for better adherence to the Outbreak Reports and Intervention Studies of Nosocomial Infection guidelines in outbreak reporting.

Latest stories

Related stories

Chinese Medtech Companies Reshape Healthcare by Innovation

The worldwide medtech spectrum is undergoing a phenomenal shift,...

The Benefits of Virtual GP Insurance: A Game Changer for Modern Healthcare

In today’s fast-paced world, accessing healthcare quickly and efficiently...

Five Data Management Questions for MedTech Leaders

Healthcare is awash in data – medical device data,...

Vaxxas Secures U.S. Patent for HD-MAP Vaccine Technology

Vaxxas, a clinical-stage biotech firm has obtained a new...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back